DAFTAR PUSTAKA

1. Ketut Suwita. Penyakit Ginjal Kronik. Aru WS, Bambang S, Idrus A,

Marcellus SK, Siti S, editor. Buku Ajar Ilmu Penyakit Dalam. Ed 4 Jilid I.
Jakarta: Fakultas Kedokteran Universitas Indonesia; 2007. Hlm- 570-3.
2. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F,
Levey AS, 2007. Prevelance of chronic kidney disease in the United States.
JAMA. 298: 2038-2047.
3. Levey, A.S., Steven, L.A., Schmid, C.H., Zhang, y., Castro, A.F., Feldman,
H.I., Kusek, J.W., Eggers, P., Lente, F.V., Greene, T., and Coresh, J. 2009. A
new equation to estimate glomerular filtration rate. Ann Intern Med. 150(9):
604-12.
4. Editorial. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease
Evaluation, Classification, and Stratification. 2011.
5. Arora P et al. Chronic Kidney Disease. Emedicine Medscape. 2019
6. Sudoyo, A.W., Setiyohadi, B., Alwi, I., Sumadibrata, M., dan Setiati. 2006.
Buku Ajar Ilmu Penyakit Dalam. Edisi IV, Jilid III. Jakarta: Pusat Penerbitan
Ilmu Penyakit Dalam FKUI.
7. Nitta, K. 2011. Review Article: Possible Link Between Metabolic Syndrome
and Chronic Kidney Disease in the Development of Cardiovaskular Disease.
Cardiol Res Pract. 10: 1-7.
8. Levin, A., Hemmelgarn, B., Culleton, B., Tobe, S., McFarlane, P., Kuzicka,
M., et al. 2008. Guidelines for the management of chronic kidney disease.
CMAJ 179(11): 1154-1162.
9. Chan, M.R., Dall, A.T., Fletcher, K.E., Lu, N., dan Trivedi, H. 2007.
Outcomes in patients with chronic kidney disease referred late to
nephrologists a meta-analysis. Am J Med. 120(12): 1063-70.
10. Prodjosudjadi, W. 2006. Incidence, prevalence, treatment and cost of end-
stage renal disease in Indonesia. Ethnic Dis. 16: S214-S216.
11. Murd et al Autogenous versus prosthetic vascular access for haemodialysis: A
systematic review and meta-analysis J Vasc Surg 2008; 48:34S-47S.
12. Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, Pannu
NI,Thomas C, Hemmelgarn BR, Craig JC, Manns B, Tonelli M, Strippoli GF,
James MT Associations between haemodialysis access type and clinical
outcomes: A systematic review. J Am Soc Nephrol 2013; 24: 465–473
13. Yeh L, Chiu S, Lai P. the impact of vascular access types on hemodialysis
patient long-term survival. Scientific reports.2019.Vol 9:10708
14. Tey R. Vascular access for haemodialysis: an unresolved issue. Nefrologia
2010;30(3):280-7
15. Hoggard J, Saad T, Schon D et al. guidelines for venous access in patients
with chronic kidney disease. Seminars in Dialysis, Vol 21, No 2 (March–
April) 2008 pp. 186–191
16. Siddiqui M, Santos D, Ashraff S. haemodialysis and vasculae access in the
end stage kidney disease. European Journal of Clinical and Biomedical
Sciences. Vol. 3, No. 1, 2017, pp. 1-6.
17. Tey R, Lopez J. Update on vascular access for hemodialysis: The new
Spanish Clinical Guideline Nefrologia. 2018;38:353–354
18. Woo K, Lok C. New Insights into Dialysis Vascular Access: What Is the
Optimal Vascular Access Type and Timing of Access Creation in CKD and
Dialysis Patients? Clin J Am Soc Nephrol. 2016
19. Sahasrabudhe P, Dighe T. Retrospective analysis of 271 arteriovenous fistulas
as vascular access for hemodialysis. Indian Journal of Nephrology. May
2013. Vol 23:3